Category Science Funding
Beware ‘Innovation-Speak’
Matthew Herder wrote a Master’s thesis on Canadian science policy some ten years ago and by the time he was done, he had sworn off the word ‘innovation.’
Resistance to Colistin: A Doomsday Scenario?
Julie Perry calls for action to prevent antibiotics resistance.
Margaret Lock Offers Dementia’s Realism Instead of Hope
Cynthia Martin writes that unlike cancer’s new push to accelerate treatment (recently launched under the banner Cancer Moonshot2020), there is no Alzheimer’s MoonShot2020.
Pharma Financialized
Matthew Herder argues that recent drug price hikes are only one part of a bigger problem with industry-driven pharmaceutical research and development.
Bill 100 and the Challenges for Indigenous Health Research
Debbie Martin argues that Section 12 of Bill 100 stifles academic freedom and potentially threatens her Indigenous health research.
Evidence and the Marketing of the HPV Vaccine
Abby Lippman, Alana Cattapan, and Kelly Holloway argue for rigorous, conflict-free research into the safety and effectiveness of the HPV vaccine and for a critical approach to its use.
Accountability for Research Misconduct
Zubin Master suggests that institutions bear some moral responsibility for research misconduct
